Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889832 | 0.86 | HPGD (0.39) | AKT1HPGDSMN1; SMN2 | |
| SCHEMBL889636 | 0.85 | AVPR1A (0.40) | AKT1HPGDSMN1; SMN2 | |
| SCHEMBL889589 | 0.79 | AVPR1A (0.46) | HPGDSMN1; SMN2 | |
| SCHEMBL889602 | 0.79 | AVPR1A (0.46) | HPGDSMN1; SMN2 | |
| SCHEMBL889641 | 0.78 | AVPR1A (0.44) | HPGDSMN1; SMN2 | |
| SCHEMBL889654 | 0.76 | AVPR1A (0.39) | HPGDSMN1; SMN2 | |
| SCHEMBL889711 | 0.76 | AVPR1A (0.45) | HPGDSMN1; SMN2 | |
| SCHEMBL889604 | 0.74 | AVPR1A (0.42) | HPGDSMN1; SMN2 | |
| SCHEMBL12349167 | 0.74 | ESR1 (0.42) | — | |
| SCHEMBL889601 | 0.73 | AVPR1A (0.37) | HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, CYP1A1 | AKT1 3907/4885HPGD 1989/4885SMN1; SMN2 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.